Summary of Classification and Labelling
Notified classification and labelling
General Information
603-973-5 |
Lithium 3[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10-13-dimethyl-1,2,4,7,8,9,10,11,12,13,14,15,16,17-tetrahydrospiro[cylopenta[a]phenantrene-3,2´-[1,3]dioxolan]-17-yl]prop-2-ynoate |
136673-12-6 |
Notified classification and labelling according to CLP criteria
Skin Sens. 1A |
H317
|
H317
|
|
|
|
|
|
|
1 |
|
View details
|
Aquatic Acute 3 |
H402
|
H402
|
Aquatic Chronic 3 |
H412
|
H412
|
Number of Aggregated Notifications: 1